Opens in a new tab

Solutions

VocaVibe Accent

Objective neurological
assessment, powered
by voice

Short, remote, repeatable assessments that support clinical decision-making across the neurological care journey.

From screening to ongoing patient management, VocaVibe adds objective, longitudinal insight with frictionless integration into both the patient’s daily life and the clinician’s workflow.

What We Enable

Remote, voice-based neurological assessment.

Objective and standardized measures that extend the value of 15-minute clinic visits and between-visit follow-ups.

Longitudinal tracking, shifting care from episodic snapshots to continuous assessment that captures change over time.

Designed to support clinicians by extending clinical visibility between visits.

Clinical Use Areas

  1. Screening

    Early identification of neurological and related symptoms using short voice recordings.

    Current focus:

    • Mild Cognitive Impairment (MCI)
    • Depression
    • Swallowing-related impairments
    • Speech impairments
    • Fall risk (coming up)

    Key characteristics:

    • One-minute voice task
    • Remote, from home
    • Supports early clinical attention and timely follow-up
  2. Neurological
    Differential Diagnosis

    Supporting clinical evaluation between neurological conditions with overlapping symptoms.

    Examples include:

    • Parkinson’s disease
    • Ataxia
    • Multiple System Atrophy (MSA)
    • Huntington’s disease
    • Dementia
    • Progressive supranuclear palsy (PSP) (coming up)

    Key characteristics:

    • Objective signal patterns derived from voice
    • Biomarkers correlated with disease-specific pathophysiology
    • Enables earlier differentiation and intervention when it matters most
  3. Neurological Patient
    Management

    Ongoing monitoring of motor and non-motor symptoms for patients with diagnosed neurological conditions.

    Current focus:

    • Parkinson’s disease
    • Cognitive decline
    • Ataxia
    • Depression

    Clinical insights supported through short voice interactions:

    • Disease staging and progression (aligned with MDS-UPDRS Parts I–IV)
    • Dysphagia monitoring (swallowing disturbance assessment)
    • Depression monitoring (aligned with Beck Depression Inventory)
    • Cognitive decline monitoring (aligned with MoCA)
    • Treatment adherence and efficacy
    • Identification of treatment side effects
    • Eligibility assessment for advanced treatments

    Key characteristics:

    • Monitoring between clinic visits
    • Supports care adjustments based on objective trends
    • Enables improved outcomes while opening new revenue opportunities for clinics
  4. TelePractice
    Enablement

    Extending neurological care beyond the clinic.

    Geography should not dictate the quality of neurological care.
VocaVibe integrates into tele-health platforms to deliver clinical-grade assessments remotely, providing actionable insights while reducing the burden of frequent in-clinic visits.

    Indications supported:

    • Swallowing impairments
    • Speech impairments

    Key capabilities:

    • Decentralized care for rural or mobility-impaired patients
    • Data-enriched tele-visits using real-time voice biomarkers
    • Closed-loop rehabilitation, connecting assessment directly to therapy for dysphagia and speech decline
    • A single referral pathway, simplifying care coordination across specialties
    • Seamless integration into tele-neurology workflows

Why This Matters
Clinically

Neurological care often relies on subjective patient self-reports and time-limited assessments.

Clinical visits are short, complex, and overloaded.

Important changes frequently occur between visits, outside clinical visibility.

Frequent, low-friction voice-based assessments provide objective data between visits, helping reduce avoidable deterioration and hospitalizations.

Evidence and Validation

VocaVibe is built on clinical research and developed in collaboration with neurological experts.

Longitudinal trial:

A landmark 18-month multi-center study establishing a new standard for remote neurological monitoring.

Scale:

Over 600 participants, 65,000 voice recordings.

Depth:

Correlated with more than 15 clinical assessments performed alongside voice capture.

0%

SENSITIVITY RATE

 

in identifying vocal markers associated with Parkinson’s Disease

 

0%

CORRELATION RATE

 

in staging and monitoring disease progression

 

0%

ACCURACY RATE

 

in detecting early signs of cognitive decline

 

0%

SENSITIVITY RATE

 

in detecting swallowing complications (dysphagia)

 

The Journey

Built to empower all
stakeholders along the
neurological patient journey

Supporting clinicians, patients, and payors across the continuum of care.

Providers & Clinics

Better care, ongoing objective clinical insights opening new revenue streams.

Learn More

Payors

Healthier insureds with lower cost of care.

Learn More

Patients

Remote assessments designed to preserve independence.

Learn More

Pharma

Better patient selection and fewer side effects.

Learn More